Sedicidodici

The company develops Smart Clot, a diagnostic platform for the In Vitro Diagnostics (IVD) market that evaluates a patient's thrombotic and hemorrhagic risk. The technology provides simultaneous measurement of platelet adhesion, aggregation, and fibrinoformation to assist in the management of cardiovascular diseases such as stroke and heart attack. The product is designed for use by clinicians, laboratory medicine specialists, and healthcare facilities.